Yale Receives More Than 5 Million Dollars In Stem Cell FundingTwelve Yale University stem cell research proposals received $5.66 million in funding from the Connecticut Stem Cell Research Advisory Committee. The grants were among $10 million awarded Tuesday to Connecticut-based state scientists in the second year of Connecticut's 10-year, $100 million grant program to fund stem cell research. The state received 87 proposals from scientists who were seeking more than $40 million under the highly competitive review process.Stem Cell Advance Yields Over 140 Cell Types From Human Embryonic Stem CellsA team of North American scientists has unveiled a new technology that could revolutionize the industrialization and commercialization of stem cell therapies. Since the first isolation of human embryonic stem cells in 1998, researchers have struggled to find a means to isolate purified populations of the many hundreds of medically-relevant cell types. Scalability has therefore been a major barrier for development of therapies on a population scale.Bio-Matrix Scientific Group, Inc. Announces It Will Open Two DNA-Genetic Testing LabsBio-Matrix Scientific Group Inc (OTCBB: BMSN), a biotechnology company focused on adult stem cell processing and cryogenic storage, announced it will open two DNA-Genetic Testing laboratories for the molecular-level detection of genes linked to specific human diseases.Symposium Explores Challenges And Promise Of Cell-Based TherapiesWhat: "Challenges and Promise of Cell-Based Therapies" is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. This will be followed by four plenary sessions that will highlight cell-based therapies for the treatment of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders.Amorcyte Completes Phase I Trial Of Stem Cell Therapy For Acute Myocardial InfarctionAmorcyte, Inc. (Amorcyte) announced the completion of the phase I clinical trial of its lead product, AMR-001 - an autologous stem cell product for the treatment of damaged heart muscle following acute myocardial infarction (AMI). "All treatment patients in each dose cohort of the phase I trial received intra-coronary artery infusion of a specified number of stem cells. The number of stem cells infused was increased over the previous cohort", said Dr.Final Data From The SEISMIC Trial Suggest Safety, Efficacy Of Autologous Stem Cell Therapy For Treating Congestive Heart FailureFinal six-month, follow-up patient data presented during the late-breaking clinical trial sessions at the American College of Cardiology, suggest MyoCell(R) myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy alone for improving heart function among patients with previously implanted cardiac devices who are experiencing congestive heart failure.Final Data From The Bioheart Seismic Trial Suggest Safety, Efficacy Of Autologous Stem-Cell Therapy For Treating Congestive Heart FailureBioheart, Inc. (Nasdaq: BHRT) announced that final six-month, follow-up patient data was presented during the late-breaking clinical trial sessions at the American College of Cardiology, suggesting that MyoCell(R) myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy alone for improving heart function among patients with previously implanted cardiac devices who are experiencing congestive heart failure.Embryos Part-animal And Part-human CreatedEmbryos that are part-human and part-animal have been created by scientists at Newcastle University, UK. The scientists, who are researching into a range of illnesses, said the embryos survived for up to three days. While religious leaders describe this development as monstrous, scientists and medical professionals hail the event as one step closer to understanding illnesses such as Alzheimer's and Parkinson's better, and ultimately being able to treat them.Stem Cells From Hair Follicles May Help 'Grow' New Blood VesselsFor a rich source of stem cells to be engineered into new blood vessels or skin tissue, clinicians may one day look no further than the hair on their patients' heads, according to new research published earlier this month by University at Buffalo engineers.
Ohio Child Custody Forms Free
Cures For Hair Loss In Women
Nature Cell Biology Focus
Womans Sexual Health Magazine
Hysterectomy Boards
Who Is More Likely To Get Chlamydia Men Or Women
Medication For Cat Allergies
Low Income Housing
Pathophysiology Of Hysterectomy
How Long Do Food Allergy Symptoms Last
Why Is Sports Good For Your Health
Chlamydia Pneumonia Symptoms
Female Practioners Feline Vaccine Advisory Panel Report
Child Birth Preparation
How To Self Check For Cervix Dialation
No comments:
Post a Comment